Tag:
computational biology
Latest Headlines
Latest Headlines
Computer-based discovery biotech from Israel lands in Bay Area
Tel Aviv-based Compugen has opened shop in a promised land of biotech, South San Francisco.
Microsoft co-founder pumping $300M into open research of the brain
Paul Allen has again promised a chunk of his multibillion-dollar fortune to understanding the circuitry of the brain and how the complex organ functions.
Sanofi secures computational help for rare disease research
Sanofi ( $SNY ) has made another move to tap external partners for new science and technology, this time in a tie-up that enables the French drug giant to benefit from computational approaches to...
J&J hires Selventa to build computerized models for personalized medicine
Selventa has embarked on a multiyear project to furnish healthcare giant Johnson & Johnson's ( $JNJ ) Janssen R&D group with disease models, in an effort to understand the mechanisms of...
A computerized blueprint for starving cancer
Cancer has a way of corrupting molecules involved in metabolism for its killer cause. Now a group of researchers has developed what they say is the first genome-scale computer model of cancer cell
Computational method rapidly discovers new uses for approved drugs
Dust off those old drugs. A Stanford University group has developed a computational method for finding potential new uses for previously approved drugs. And two papers published Wednesday in the
Virtual rats in the works to aid disease research
While we're far from doing away with sacrificing living rodents in the name of science, researchers at the Medical College of Wisconsin in Milwaukee are working away at developing in silico critters
Two computational biology standouts honored
A pioneer and an up-and-comer in the field of computational biology have garnered awards from the International Society of Computational Biology. The first award, for a senior scientist in the field,
Scientists mount computer-aided attack on H1N1 flu virus
Researchers have used computational tools for designing new proteins to incapacitate a strain of flu virus. Their research in the May 12 edition of Science shows that the computer-aided approach has
David Shaw goes from high finance to high-tech biotech simulations
Forbes blogger Tom Groenfeldt ordinarily writes about financial technology, but the worlds of hedge fund technology and computational biochemistry collide in David Shaw, founder of D.E. Shaw fund
